Beiersdorf's group sales reached a record high last year, at €9.5 billion, representing an organic increase of 10.8%.
Earnings before investment and taxes (EBIT) increased from €1,158 million in 2022 to €1,268 million, resulting in an improved EBIT margin of 13.4% (2022: 13.2%).
Beiersdorf’s brand icon NIVEA – including Labello – delivered its best performance of the century, surpassing the €5 billion sales threshold for the first time in its history.
Nominal sales of €5.2 billion in 2023 translate into organic growth of 16.2%. All regions and categories contributed to this result with double-digit growth as well as the strong e-commerce business, where NIVEA gained market shares in 2023.
The Derma business, which includes the brands Eucerin and Aquaphor, continued its impressive success story with organic sales growth of 24%. Nominal sales increased to €1.3 billion. This result was driven by the global outperformance of the Sun Care product range, continued expansion of the e-commerce business, the popularity of products featuring the hero ingredient Thiamidol and the success of the portfolio in Latin America, the Middle East and Africa.
The Healthcare business, which mainly comprises the plaster brands Hansaplast and Elastoplast, reported organic sales growth of 4.2% and achieved sales of €267 million.
This increase was driven by the success of large plasters for post-operative wound care and several brand innovations in the injury care category. This growth was seen in all major markets and was especially fueled by a strong performance in the Emerging Markets region.
Overall, Hansaplast strengthened its top position in the market with continuous market share gains in fiscal year 2023.
Vincent Warnery, CEO of Beiersdorf: “We continued our remarkable growth trajectory of recent years, again achieving double-digit organic sales growth in a difficult market environment.
"We were the fastest-growing beauty company worldwide in 2023 and we kept our promise of profitable growth. NIVEA delivered impressive levels of growth across all regions and categories, leading to record sales of over €5 billion.
"The strategic recalibration of NIVEA’s operating model toward a more globalised and digital approach is producing the desired results and laying the foundation for continued growth.
"Our Derma business also grew by 24%, which marks the third consecutive year of double-digit growth for our brands Eucerin and Aquaphor.
"This success makes us confident in our vision to become the best skin care company in the world, a vision that requires continuous progress.
"2023 was also a year marked by substantial strategic investments in our digital and physical infrastructure, our innovative strength, our sustainability progress, and in our people. These steps will ensure that we can deliver continued strong growth in the future.”
Nivea delivered “best performance of the century” last year
